New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.
Sydney Crago
Advertisement
Sydney Crago is managing editor of the Eyecare Network at MJH Life Sciences.
Articles by Sydney Crago
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
ACIP to vote on major hepatitis B vaccine update that could reshape the childhood vaccine schedule
2
Transplant-fueled hybrid immune systems may help reverse Type 1 diabetes
3
New test may solve the specificity and false-positive problems of the PSA test for prostate cancer
4
Biosimilar denosumab could save $0.59 per member per month
5
